Annual report pursuant to Section 13 and 15(d)

10. Subsequent Events

v3.8.0.1
10. Subsequent Events
12 Months Ended
Dec. 31, 2017
Subsequent Events [Abstract]  
Subsequent Events

Cancer Research UK Termination of CTOA

 

On March 21, 2018 Cancer Research UK notified the Company that it was terminating the CTOA and would work to transfer to the Company the data and know-how generated under the CTOA. The Company is currently reviewing potential alternative collaboration opportunities for MNPR-101 and continues to maintain the program’s intellectual property portfolio. 

 

The Company has evaluated all events occurring from December 31, 2017 through March 26, 2018, the date which these financial statements were available to be issued, and did not identify any additional material disclosable subsequent events.